75A50126F61014↗

Name: 75A50126F61014: Manufacture and Stability Studies of Thimerosal-Free Pandemic Influenza Vaccine Multidose Vials (MDVS)
Creator: SpendQuery
License: https://creativecommons.org/licenses/by/4.0/

Seqirus Inc received this contract from Barda - Aspr / Daappo / Barda Dcma, Office of Assistant Secretary for Preparedness and Response: $2.15M obligated so far for drugs and biologicals. It runs to 2028-09-29, or to 2029-09-29 if every option is exercised.

Key facts · data as of Oct 22, 2026

Recipient: Seqirus Inc
Awarding agency: Office of Assistant Secretary for Preparedness and Response (Department of Health and Human Services)
Contracting office: Barda - Aspr / Daappo / Barda Dcma (75A501)
Obligated to date: $2.15M
Potential value: $28.69M
Ends: 2028-09-29

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 22, 2026.

Cite this page: SpendQuery, Award 75A50126F61014, data as of Oct 22, 2026, https://spendquery.com/award?id=CONT_AWD_75A50126F61014_7505_75A50122D00004_7505

Seqirus Inc: all federal awards · Department of Health and Human Services: spending · Barda - Aspr / Daappo / Barda Dcma: what it buys · The follow-on: recompete brief

MANUFACTURE AND STABILITY STUDIES OF THIMEROSAL-FREE PANDEMIC INFLUENZA VACCINE MULTIDOSE VIALS (MDVS)

Delivery Order · Office of Assistant Secretary for Preparedness and Response · to Seqirus Inc (UEI Z6N1LJ2RD6E3) · data as of 2026-10-22

Obligated to date$2.15M1 action

Current value$2.15Mwith options exercised

Potential value$28.69Mif every option is used

Period2026-09-30 → 2028-09-29up to 2029-09-29 with options

Up for re-bid: ends 2028-09-29. Recompete brief →

What it is

Product or service: Drugs and Biologicals (PSC 6505)
Industry: Biological Product (Except Diagnostic) Manufacturing (NAICS 325414)
Contracting office: Barda - Aspr / Daappo / Barda Dcma (75A501)
Competition: Full and open competition
Pricing: Firm fixed price
How it was bought: Single-award IDIQ · under 75A50122D00004
Where the work is: Wake, NC · district NC-13

Obligations by fiscal year

FY2026$2.15M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

1 action since 2026-09-24. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-09-24	0		$2.15M	MANUFACTURE AND STABILITY STUDIES OF THIMEROSAL-FREE PANDEMIC INFLUENZA VACCINE MULTIDOSE VIALS (MDVS)

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-22). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗